Evolution of Quality of Life in Persons with Parkinson’s Disease: A Prospective Cohort Study
Autor: | Eduardo Candel-Parra, Antonio Hernández-Martínez, María Pilar Córcoles-Jiménez, Milagros Molina-Alarcón, Victoria Delicado-Useros |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Activities of daily living Article 03 medical and health sciences Social support 0302 clinical medicine Quality of life medicine Apathy no-motor symptoms 030212 general & internal medicine Prospective cohort study business.industry General Medicine motor symptoms PDQ 39 Confidence interval Mood quality of life Physical therapy Parkinson’s disease Medicine medicine.symptom business 030217 neurology & neurosurgery Cohort study |
Zdroj: | Journal of Clinical Medicine Journal of Clinical Medicine, Vol 10, Iss 1824, p 1824 (2021) Volume 10 Issue 9 |
ISSN: | 2077-0383 |
Popis: | Parkinson’s disease (PD) is a chronic neurodegenerative disorder that results in important functional symptoms, altered mood, and deterioration in quality of life (QoL). This study aimed to determine the evolution of the QoL in persons with PD in the Albacete health district over a two-year period and identify associated sociodemographic, clinical, and socio-health characteristics. A cohort study was conducted of patients at different stages of PD in the Albacete health district. Calculated sample size: 155 patients. Instruments: A purpose-designed questionnaire for data collection and the “Parkinson Disease Questionnaire” (PDQ-39), which measures 8 dimensions and a global index where a higher score indicates worse quality of life. Three measurements were made: baseline, one year, two years. A descriptive and bivariate analysis was conducted. Ethical aspects: informed consent, anonymized data. Results: Mean age 69.51 (standard deviation, SD 8.73) years, 60% male, 75.5% married, and 85.5% lived with family. The most frequent motor symptoms were slow movement (86.23%), postural instability (55.5%), tremor (45.5%), and dyskinesia (24.6%). Among the non-motor symptoms were fatigue (66.2%), pain, daytime somnolence, constipation, and apathy, with approximately 50% each. The mean QoL score at baseline was 27.47 (SD 16.14) 95% CI (confidence interval) 24.91–30.03. At two years, global QoL had slightly worsened (28.3 SD 17.26 95% CI 25.41–31.18), with a statistically significant worsening in mobility, activities of daily living, and communication, whereas social support improved. |
Databáze: | OpenAIRE |
Externí odkaz: |